The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random and not inherited by her children.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial when the cancer returned.
Picking a Clinical Trial for Pancreatic Cancer Treatment
When Robert Weker was diagnosed with pancreatic cancer, he believed a clinical trial was his best chance of reducing the tumor enough for a Whipple.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D'Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
Where Sorrow and Joy Meet
Musician and producer Tom Bajoras has focused on the sorrow, joy, and beauty of life as he fights PNET with standard and new treatments.
I’ll Never Stop Fighting
When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.
Relocating For Pancreatic Cancer Treatment and a Clinical Trial
Rachel Moreno knew she would need help during treatment for pancreatic cancer but moving in with her son also gave her access to a clinical trial.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker realized he needed to try many different treatments, including clinical trials.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Life With Pancreatic Cancer and on Clinical Trials
After a pancreatic cancer diagnosis, former basketball coach and GM Rob Babcock realized his best chance was with clinical trials.